Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9AEK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,934
Award facts
- Contract value 100% obligated
- $24,934.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $24,934 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body 2.4 ml pharmaceutical supplies. This non-set-aside award was executed on November 24, 2025, with an ultimate completion date of December 16, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. SKYRIZI is a biologic medication used in the treatment of inflammatory skin conditions, representing the type of specialty pharmaceutical product the company routinely supplies through federal medical procurement channels.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains a substantial portfolio of competitively awarded contracts with the DLA for supplying a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems worldwide. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its expansive distribution network, positions it as a key provider for the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F9AEK?
SPE2DR26F9AEK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9AEK worth?
The government has obligated $24,934 on SPE2DR26F9AEK.
Is contract SPE2DR26F9AEK an order under another contract?
Yes. SPE2DR26F9AEK is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9AEK competed?
The extent of competition for SPE2DR26F9AEK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award